Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Ninth Circuit revives trade secrets claims in DNA-sequencing spat
Americas
Ninth Circuit revives trade secrets claims in DNA-sequencing spat
Plaintiff accuses defendant of “locking” employees out of office to steal secrets | Ruling rejects California’s stricter rule for federal DTSA cases | Decision may shape plaintiffs’ choice of legal claims in future disputes in the state.   13 August 2025
Latham steps into dispute over $6bn treatment, replacing Kirkland
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
Firm takes over Novartis in major patent litigation | Move follows rival firm's withdrawal after conflict-of-interest challenge | Latham team led by new hire from Cravath.   13 August 2025
Harvard’s patent portfolio at risk as Trump turns up the pressure
Americas
Harvard’s patent portfolio at risk as Trump turns up the pressure
Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts.   11 August 2025
Careers
Weil adds leaders from Latham to head up tech and life sciences
The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.   11 August 2025
Europe
CyDex trade secrets case tossed by Italian court in rare ruling
Captisol dispute intensifies as Italian court sides with Bexson | CyDex claims of trade secret misuse dismissed in early-stage ruling | Case relates to ongoing US dispute.   7 August 2025
Europe
European Patent Office’s G1/25 referral under the microscope
A much-anticipated referral could upend the EPO’s controversial description amendment rule—and reshape European patent practice, as the Enlarged Board of Appeal prepares to weigh in on G 1/25.   5 August 2025
Europe
Pfizer loses UK appeal over Moderna Covid-19 vaccine patent
UK Court of Appeal upholds key Moderna patent against Pfizer and BioNTech | Comirnaty vaccine ruled to infringe European mRNA technology patent.   4 August 2025
Europe
Bayer’s Xarelto patent struck down by German court
German Federal Patent Court invalidates key patent for Xarelto | Bayer faces intensifying generic competition across Europe | Legal team highlights Germany’s crucial role in patent litigation and the importance of stopping early generic entry to protect market exclusivity.   1 August 2025
Europe
Xanax owner fends off ‘Canvax’ mark in EU
The pharma manufacturer defeats an Italian hemp firm’s EU trademark bid | Claimed name could be confused for its blockbuster drug Xanax | EUIPO found strong market position and product overlap created risk of confusion.   31 July 2025
Careers
Four-lawyer team joins Cozen O’Connor’s new San Diego office
The team brings decades of litigation experience, with practices covering sectors from AI and life sciences to software and medical devices, as the firm prepares to open a new office in San Diego.   31 July 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.